Company intelligence / Profile preview

Oova

New York City, New York, United Statesoova.life ↗

Ownership: Private
Development stage: Commercial

Overview

Oova has developed and commercialized an at-home diagnostic platform that quantitatively measures key fertility hormones—luteinizing hormone, E3G, and PdG—using urine samples. The results are interpreted via a smartphone app using AI to provide daily insights into ovulation and fertility status. The product is available for consumer use and is positioned as more accurate than traditional ovulation prediction kits due to its quantitative approach and ability to track multiple hormones over time.

Therapeutic areas: Women's Health
Modalities: DeviceNon-pharmacological therapy (hormone monitoring)
Industry: Physiological Monitoring

Partnerships

Thorne Research

Beyond the preview

Go deeper on Oova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oova.

Explore the full profile